Turbine and Crown Bioscience, a global contract research organization (CRO) and a JSR Life Sciences company, today announced a strategic partnership to advance translational oncology research by integrating Turbine’s in silico Virtual Assays with its Tumor Organoid Assays based on HUB Organoid Technology.